ZIVO Bioscience, Inc. (ZIVO)

USD 16.02

(-15.68%)

Net Debt Summary of ZIVO Bioscience, Inc.

  • ZIVO Bioscience, Inc.'s latest annual net debt in 2023 was 71.96 Thousand USD , up 105.31% from previous year.
  • ZIVO Bioscience, Inc.'s latest quarterly net debt in 2024 Q2 was 575.98 Thousand USD , down -10.06% from previous quarter.
  • ZIVO Bioscience, Inc. reported annual net debt of -1.35 Million USD in 2022, up 84.34% from previous year.
  • ZIVO Bioscience, Inc. reported annual net debt of -8.64 Million USD in 2021, down -265.72% from previous year.
  • ZIVO Bioscience, Inc. reported quarterly net debt of 575.98 Thousand USD for 2024 Q2, down -10.06% from previous quarter.
  • ZIVO Bioscience, Inc. reported quarterly net debt of 1.48 Million USD for 2023 Q2, up 97.96% from previous quarter.

Annual Net Debt Chart of ZIVO Bioscience, Inc. (2023 - 2000)

Historical Annual Net Debt of ZIVO Bioscience, Inc. (2023 - 2000)

Year Net Debt Net Debt Growth
2023 71.96 Thousand USD 105.31%
2022 -1.35 Million USD 84.34%
2021 -8.64 Million USD -265.72%
2020 5.21 Million USD 5.74%
2019 4.93 Million USD -72.23%
2018 17.76 Million USD 1.4%
2017 17.52 Million USD 78.75%
2016 9.8 Million USD 59.54%
2015 6.14 Million USD 53.4%
2014 4 Million USD 98.56%
2013 2.01 Million USD 56.58%
2012 1.28 Million USD 151.04%
2011 513.14 Thousand USD 106.05%
2010 249.04 Thousand USD -38.19%
2009 402.91 Thousand USD 144.39%
2008 164.86 Thousand USD -43.19%
2007 290.21 Thousand USD -40.17%
2006 485.06 Thousand USD 438.98%
2005 89.99 Thousand USD -84.16%
2004 568.24 Thousand USD 63590.61%
2003 -895.00 USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%

Peer Net Debt Comparison of ZIVO Bioscience, Inc.

Name Net Debt Net Debt Difference
America Great Health 1.81 Million USD 96.038%
Ampio Pharmaceuticals, Inc. -3.81 Million USD 101.886%
Aridis Pharmaceuticals, Inc. 1.25 Million USD 94.261%
Biora Therapeutics, Inc. 32.21 Million USD 99.777%
Bio-Path Holdings, Inc. -939 Thousand USD 107.664%
Better Therapeutics, Inc. -860 Thousand USD 108.368%
Calithera Biosciences, Inc. -23.78 Million USD 100.303%
Comera Life Sciences Holdings, Inc. 328.44 Thousand USD 78.09%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 4.57 Million USD 98.425%
Eloxx Pharmaceuticals, Inc. -5.82 Million USD 101.236%
Evelo Biosciences, Inc. 3.19 Million USD 97.75%
Evolutionary Genomics, Inc. 3.16 Million USD 97.728%
Finch Therapeutics Group, Inc. 5 Million USD 98.561%
Galera Therapeutics, Inc. 134.04 Million USD 99.946%
Innovation1 Biotech Inc. 179.15 Thousand USD 59.831%
Kiromic BioPharma, Inc. 12.33 Million USD 99.417%
Molecular Templates, Inc. 707 Thousand USD 89.821%
Navidea Biopharmaceuticals, Inc. 438.44 Thousand USD 83.587%
NexImmune, Inc. -3.13 Million USD 102.296%
Orgenesis Inc. 21.78 Million USD 99.67%
Panbela Therapeutics, Inc. 2.61 Million USD 97.249%
Point of Care Nano-Technology, Inc. -498.00 USD 14550.201%
PaxMedica, Inc. Common Stock -4.71 Million USD 101.528%
Scopus BioPharma Inc. -124.57 Thousand USD 157.766%
Sorrento Therapeutics, Inc. 110.87 Million USD 99.935%
Statera Biopharma, Inc. 14.41 Million USD 99.501%
TRACON Pharmaceuticals, Inc. -7.59 Million USD 100.947%
Trevena, Inc. 2.25 Million USD 96.813%
Vaxxinity, Inc. 10.13 Million USD 99.29%
Vaccinex, Inc. -1.28 Million USD 105.587%
Vicapsys Life Sciences, Inc. 344.44 Thousand USD 79.108%
Viracta Therapeutics, Inc. 13.23 Million USD 99.456%